Sunday, July 18, 2010

Good times ahead?

What a beautiful weekend. Great weather, multiple gatherings at friends, and squeezed in a quick 5 mile run down the Huron River.

I happened to download the most recent
PwC/NVCA MoneyTree Report in raw data format. A lot of interesting observations, but some are as follows:

  • upward quarterly trend in total $ and # deals invested with slight dip in Q1 2010, resulting in a more favorable H1 2010 vs H1 2009 comparison.
  • 2009 H1 vs 2010 H1, $ and deals:
Biotech: 35% increase, 24% increase
Financial services: 213%, 62%
Med Device/Equipment: 13%, 9%
All: 49%, 23%
  • cleantech investments: higher # deals and $ invested, 64% and 203% respectively, 2009 H1 vs 2010 H1; already invested more $ as of H1 than total 2009 $.
  • initial investments in 2010 H1 in Seed and Early Stage companies outweighed investments in Expansion and Later Stage companies by over 50%; there were also increases in # of deals and $ invested in Seed and Early Stage companies attracting initial investments.
  • last quarter, 2010 Q2, biotech sector received the largest level of funding of all sectors- $1.3B.
  • average initial investments in seed, early stage, expansion, and later stage companies in 2010 H1 were $4.5M, $3M, $7M, and $5M.
  • initial investments in biotech increased by 60% and 79% in $ invested and # deals, respectively, in a 2009 H1 vs 2010 H1 comparison. 17% of the initial $ invested in 2010H1 went to biotech (at an average of $5M per deal), surpassed only by software where 18% of the initial $ invested went. Med Devices/Equipment and Healthcare services garnered 9% and 2%, respectively, of initial investments in 2010 H1.
  • the largest number of deals to receive initial investments in the first half of this year were software (25%), followed by biotech (14%). Med Devices/Equipment and Healthcare Services comprised 6% and 1%, respectively, of the total number of deals to receive initial investments.
  • Michigan data indicates declining $ and deals invested from 2009 Q3 ($36M; 9 deals) through 2010 Q1 ($14M; 4 deals) with an improvement in 2010 Q2 ($45M; 10 deals).

Some points to highlight:

  • Quarterly trends are encouraging for early stage entrepreneurs
  • Overall investment trends encouraging
  • Biotech and Cleantech sectors are but 2 sectors with encouraging initial investment data; the former having particularly encouraging total investment $ data coming off of last quarter as the sector receiving the largest pool of investor $, and the latter finally getting the pickup it needs to really be impactful despite the dearth of exits in this space
  • Greater investment $ and deals going to the seed/early-stage space
  • Investments in Michigan remain tepid with encouraging growth in the first two quarters of this year; my assessment from speaking with investors and hearing exciting, yet-to-be-publicized news from a number of companies across the state is that we will end 2010 with many more $ and deals invested vs. 2009

No comments:

Post a Comment